Clinical Trial: A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A

U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07416526) titled 'A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A' on Feb. 11.

Brief Summary: The purpose of this study is to evaluate the efficacy, safety, pharmacokinetics and pharmacodynamics of NXT007 prophylaxis compared with Factor VIII (FVIII) prophylaxis in participants with severe or moderate congenital hemophilia A without inhibitors. The study will include people aged >=12 years old with severe or moderate congenital hemophilia A without inhibitors on previous FVIII prophylaxis treatment.

Study Start Date: May 09, 2026

Study Type: INTERVENTIONAL

Condition: Hemophi...